THURSDAY, Sept. 11, 2024 (HealthDay News) — Two monoclonal antibody treatments to slow Alzheimer’s disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years. It’s thought the drugs curb Alzheimer’s by reducing levels of toxic amyloid protein plaques inContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Black stroke victims are arriving at emergency rooms much later than white patients, greatly increasing their risk of death or lifelong disability, a new study finds. Every second counts when it comes to treating a stroke, experts say. Any moment’s delay allows forContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it forContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Less than half of people who’ve survived a stroke will go on to have a healthy, normal sleep pattern, new research shows. Normal sleep is defined as six to eight hours of shuteye nightly. However, a majority of the nearly 1,600 stroke survivorsContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid,Continue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — An experimental weight-loss pill appears to help people quickly shed pounds, a new study says. People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European AssociationContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been designed to require injections only once aContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Contrary to a warning placed on labels for CART-T cancer therapies, use of these treatments does not appear to boost the odds for a secondary cancer later, a new study shows. Researchers at Memorial Sloan Kettering Cancer Center (MSKC) in New York CityContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — People with diabetes are more prone to gum disease, due to the damage the chronic illness does to small blood vessels, a new study warns. Diabetics who suffer from other diseases caused by small blood vessel damage — diabetic retinopathy and neuropathy — areContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Widespread and easy access to guns is the reason behind the shockingly high rate of firearm deaths in the United States, and not any rise in mental health problems suffered by perpetrators, a new study shows. The United States has the same burdenContinue Reading